Nektar Therapeutics NKTR Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's common stock shares issued?
- Nektar Therapeutics (NKTR) reported common stock shares issued of 29.5M in Q1 2026.
- How has Nektar Therapeutics's common stock shares issued changed year-over-year?
- Nektar Therapeutics's common stock shares issued decreased by 84.8% year-over-year, from 194.4M to 29.5M.
- What is the long-term trend for Nektar Therapeutics's common stock shares issued?
- Over 3 years (2022 to 2025), Nektar Therapeutics's common stock shares issued has grown at a -46.1% compound annual growth rate (CAGR), from 188.6M to 29.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.